VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

NCT00431353 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

DRUG: Ganciclovir
DRUG: valganciclovir [Valcyte]

Sponsor

Hoffmann-La Roche